LOS ANGELES - nvtip -- myLAB Box, the first nationwide at-home testing-to-treatment service, announced today the launch of their COVID-19 at-home test pre-sale. The pre-sale is now open to all professional entities such as clinics, doctor's offices, pharmacies and more. Plans to announce a direct-to-consumer solution are imminent.

With mounting demand and escalating pressure surrounding the coronavirus pandemic nationwide, at-home testing offers invaluable opportunity to diagnose, treat and quarantine simultaneously. Being able to test from home means a lower risk to get or spread the infection among the public as well as a safer environment for healthcare professionals.

The company plans to offer the tests at cost to support emergency response efforts and ensure affordability of screening. All myLAB Box tests will come with free 24 hour shipping and telemedicine consultations if purchased from the retailer directly. Consumers who receive a kit directly from their preferred physician can enjoy seamless support by automatically sharing results with their providers.

More on nvtip.com

• Beycome Closes $2.5M Seed Round Led by InsurTech Fund
• Tru by Hilton Columbia South Opens to Guests
• Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
• "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
• Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026

"U.S. healthcare systems are strained and may reach their limits due to the COVID-19 pandemic," said myLAB Box CEO and Co-founder Lora Ivanova. "Increases in demand at care centers and labs require innovative solutions to address shortages and improve access to potentially infected patients. The WHO and CDC agree that testing is the foundation of an effective public health response to save lives. By opening sales to professional healthcare providers first we aim to alleviate some of the challenges they are struggling with, allowing them to better serve their patients anytime and anywhere."

According to the CDC, to-date roughly only 20,000 Americans have been able to receive the much needed COVID-19 diagnostic test. A lack of test kits, testing supplies, lab staffing and equipment has slowed clinical efforts.

myLAB Box projects reaching daily volumes of up to 20,000 tests following a ramp-up period, offering encouraging news for healthcare professionals and consumers alike.

myLAB Box offers a broad range of at-home tests including tests for sexual health, nutrition, strep, flu, and general wellness.

To apply for a partner account and participate in the pre-sale, visit www.mylabbox.us or contact customerservice@mylabbox.com. To sign up for updates on the imminent direct to consumer launch, visit www.mylabbox.com.

More on nvtip.com

• Women's Everyday Safety Is Changing - The Blue Luna Shows How
• Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
• 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
• The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
• AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue

About myLAB Box

Founded in 2013, myLAB Box is the first company to offer a nationwide at-home screening platform for STDs. All myLAB Box tests use FDA-approved technology and are validated by fully licensed CLIA-certified myLAB Box lab affiliates with extensive experience in testing for infectious diseases. By offering testing, screening or testing services direct to consumers, myLAB Box is able to offer exceptional service at half the cost of conventional lab tests. From affordable screening to complimentary physician consultations for positives, every aspect of the myLAB Box service is designed to be safe, effective and efficient. Headquartered in Los Angeles, California. For more information, visit: www.mylabbox.com.